DE2157112C3 - Benzodiazepin-Derivat - Google Patents

Benzodiazepin-Derivat

Info

Publication number
DE2157112C3
DE2157112C3 DE2157112A DE2157112A DE2157112C3 DE 2157112 C3 DE2157112 C3 DE 2157112C3 DE 2157112 A DE2157112 A DE 2157112A DE 2157112 A DE2157112 A DE 2157112A DE 2157112 C3 DE2157112 C3 DE 2157112C3
Authority
DE
Germany
Prior art keywords
dihydrochloride
monohydrochloride
flurazepam
dihydro
fluorophenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2157112A
Other languages
German (de)
English (en)
Other versions
DE2157112B2 (de
DE2157112A1 (de
Inventor
Joseph Dr. Basel Hellerbach
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE2157112A1 publication Critical patent/DE2157112A1/de
Publication of DE2157112B2 publication Critical patent/DE2157112B2/de
Application granted granted Critical
Publication of DE2157112C3 publication Critical patent/DE2157112C3/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE2157112A 1971-06-08 1971-11-17 Benzodiazepin-Derivat Expired DE2157112C3 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH832571A CH553792A (de) 1971-06-08 1971-06-08 Verfahren zur herstellung von 7-chlor-1-(2-diaethyl-aminoaethyl)-5-(2-fluorphenyl)-1,3-dihydro-2h-1,4-benzodiazepin-2-on-monohydrochlorid.

Publications (3)

Publication Number Publication Date
DE2157112A1 DE2157112A1 (de) 1972-12-28
DE2157112B2 DE2157112B2 (de) 1980-10-09
DE2157112C3 true DE2157112C3 (de) 1981-09-03

Family

ID=4338591

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2157112A Expired DE2157112C3 (de) 1971-06-08 1971-11-17 Benzodiazepin-Derivat

Country Status (31)

Country Link
JP (1) JPS5230568B1 (ro)
AT (1) AT313281B (ro)
BE (1) BE777897A (ro)
BG (1) BG19173A3 (ro)
BR (1) BR7108123D0 (ro)
CA (1) CA945989A (ro)
CH (1) CH553792A (ro)
CS (2) CS155106B2 (ro)
CY (1) CY868A (ro)
DD (1) DD98679A5 (ro)
DE (1) DE2157112C3 (ro)
DK (1) DK127506B (ro)
ES (1) ES397552A1 (ro)
FI (1) FI51352C (ro)
FR (1) FR2140371B1 (ro)
GB (1) GB1331823A (ro)
HU (1) HU170152B (ro)
IE (1) IE35846B1 (ro)
IL (1) IL38252A (ro)
KE (1) KE2652A (ro)
LU (1) LU65469A1 (ro)
MX (1) MX149567A (ro)
MY (1) MY7400115A (ro)
NL (1) NL7116376A (ro)
NO (1) NO133714C (ro)
PH (1) PH13530A (ro)
PL (1) PL81437B1 (ro)
RO (2) RO59000A (ro)
SE (2) SE388856B (ro)
SU (1) SU475776A3 (ro)
ZA (1) ZA717880B (ro)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1199304A1 (en) * 1997-03-05 2002-04-24 Takeda Chemical Industries, Ltd. Bicyclic compounds and pharmaceutical composition containing tricyclic compound for treating or preventing sleep disorders

Also Published As

Publication number Publication date
GB1331823A (en) 1973-09-26
DD98679A5 (ro) 1973-07-05
FI51352C (fi) 1976-12-10
IL38252A (en) 1974-11-29
BE777897A (fr) 1972-07-11
SU444369A3 (ru) 1974-09-25
MY7400115A (en) 1974-12-31
KE2652A (en) 1976-08-13
IL38252A0 (en) 1972-01-27
CY868A (en) 1976-12-17
JPS5230568B1 (ro) 1977-08-09
HU170152B (ro) 1977-04-28
SE7513088L (sv) 1975-11-20
CS155105B2 (ro) 1974-05-30
DE2157112B2 (de) 1980-10-09
NL7116376A (ro) 1972-12-12
FR2140371A1 (ro) 1973-01-19
SE388856B (sv) 1976-10-18
PL81437B1 (ro) 1975-08-30
SU475776A3 (ru) 1975-06-30
AT313281B (de) 1974-02-11
CH553792A (de) 1974-09-13
CS155106B2 (ro) 1974-05-30
BG19173A3 (ro) 1975-04-30
CA945989A (en) 1974-04-23
IE35846L (en) 1972-12-08
RO58965A (ro) 1975-09-15
FI51352B (ro) 1976-08-31
ES397552A1 (es) 1975-03-16
NO133714B (ro) 1976-03-08
LU65469A1 (ro) 1973-12-14
IE35846B1 (en) 1976-06-09
ZA717880B (en) 1973-01-31
NO133714C (ro) 1976-06-16
RO59000A (ro) 1975-12-15
FR2140371B1 (ro) 1975-06-13
MX149567A (es) 1983-11-25
DK127506B (da) 1973-11-19
PH13530A (en) 1980-06-19
DE2157112A1 (de) 1972-12-28
BR7108123D0 (pt) 1973-07-03

Similar Documents

Publication Publication Date Title
DE3143219C2 (ro)
DE1793208A1 (de) Neue cyclische Kohlenwasserstoffverbindungen
DE2445584B2 (de) L- bzw. DL-2-Methyl-3- (3', 4'-dihydroxyphenyl)-alanin-ester, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE1802394C2 (de) Arzneimittel mit antihypertensiver Wirkung, die [(2,6-Dichlorbenzyliden)-amino]-guanidin oder ein Säureadditionssalz davon enthalten
DE3125471C2 (de) Piperazinderivate, Verfahren zu ihrer Herstellung und Arzneimittel, die diese Verbindungen enthalten
DE2846251A1 (de) Guanidinbenzoesaeureverbindungen, verfahren zu deren herstellung und arzneimittel, welche diese enthalten
DE2439859A1 (de) Verfahren zur herstellung von 3-(3,4dihydroxy-phenyl)-serin
DE3016752A1 (de) Verfahren zur herstellung von 2-isopropylaminopyrimidinhydroxy-derivaten
CH634060A5 (de) Verfahren zur herstellung neuer (3-amino-5-substituierter-6-fluorpyrazinoyl- oder -pyrazinamido)-guanidine und deren derivate.
AT390616B (de) Verfahren zur herstellung von neuem, kristallinem cephalexinhydrochloridmonohydrat und dessen verwendung zur herstellung eines arzneimittels
DE2157112C3 (de) Benzodiazepin-Derivat
DE69015834T2 (de) 6-Chlor-7,8-dihydroxy-1-(4'-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzodiazepin-carbamate als Pro-Arzneimittel.
DE2523250C2 (ro)
DE2726849A1 (de) Dihydro- und tetrahydro-iminothiazine
DE3139554C2 (ro)
DE1963317A1 (de) Chemische Verfahren und Produkte
DE10044905A1 (de) (2-Azabicyclo[2.2.1]hept-7-yl)methanol-Derivate als nikontinische Acetylcholinrezeptor Agonisten
DE1915230B2 (de) Hydroxyphenylalkylaminderivate, verfahren zu deren herstellung und arzneimittel auf deren basis
DE3121175A1 (de) Erythro-1,2,3-triphenyl-1-pentanon-derivate sowie verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE2259471C2 (de) 2-Halogen-9-phenyl-5,6-dihydro-7H-pyrido [2,3-f] [1,4] diazepinderivate
DE3105122C2 (de) Neue Piperazin-Verbindungen, Verfahren zu ihrer Herstellung und diese enthaltende Immunverstärker
DE1906322A1 (de) Neue alpha-Alkyl-5-hydroxytryptophanester
DE1518125A1 (de) Aminosaeureamide und Verfahren zu ihrer Herstellung
AT311363B (de) Verfahren zur Herstellung von neuen Benzodiazepinderivaten und ihren Säureadditionssalzen
DE2053205A1 (de) Dihydrofurandenvate und Verfahren zu deren Herstellung

Legal Events

Date Code Title Description
OI Miscellaneous see part 1
C3 Grant after two publication steps (3rd publication)